ArticleLeukemia & lymphoma2018

A tool compound targeting the core binding factor Runt domain to disrupt binding to CBFβ in leukemic cells.

Zaw Min Oo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.